Go to Top
[maxbutton id="1"]

Local Start-Up Developing Melanoma Technology Will Partner with National Cancer Institute for Pre-clinical Testing

Stuart Rose, co-founder and board chair of local start-up SolaranRx, Inc.  announced that the company will team up with the National Cancer Institute for pre-clinical testing of technology the company is commercializing for the diagnosis and treatment of metastatic melanoma.  The technology was developed at the University of New Mexico by Dr. Yubin Miao, former associate professor in the UNM departments of pharmaceutical sciences and dermatology.  To read more about this latest development, see Kevin Robinson-Avila’s January 11, 2016 article, “ABQ firm partners with National Cancer Institute,” from ABQJournal Online, reprinted below. Also see Megan Cruz’ February 18, 2016 KOAT report, at http://www.koat.com/news/area-company-targets-melanoma-cure-by-targeting-cells/38046660.

ABQ firm partners with National Cancer Institute